Contract 36F79724D0048
Moderna Us, Inc. · Department Of Veterans Affairs · September 4, 2024
Moderna Us, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 4, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 10 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 29, 2025. If all options are exercised, the contract could reach $225,000.
Contract details
- PIID
- 36F79724D0048
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 4, 2024
- Latest action
- December 29, 2025
Description
VOLUNTARY PRICE DECREASE FOR THREE PRODUCTS
Modification timeline
-
December 29, 2025Mod P00019 · Supplemental Agreement For Work Within Scope$0
-
December 22, 2025Mod P00018 · Supplemental Agreement For Work Within ScopeADDING ONE 42-2A PRODUCT TO CONTRACT$0
-
December 17, 2025Mod P00017 · Supplemental Agreement For Work Within ScopeTEMPORARY LIFE CYCLE FOR 3 NDCS$0
-
December 3, 2025Mod P00016 · Supplemental Agreement For Work Within ScopeINCORPORATING THE 2026 PUBLIC LAW PRICING UPDATE FOR 1 PRODUCT$0
-
November 17, 2025Mod P00015 · Supplemental Agreement For Work Within ScopeADDING ONE VACCINE TO THE FSS CONTRACT$0
-
October 27, 2025Mod P00014 · Supplemental Agreement For Work Within ScopeVOLUNTARY PRICE DECREASE FOR TWO PRODUCTS.$0
-
October 22, 2025Mod P00013 · Supplemental Agreement For Work Within ScopeREMOVING THREE PRODUCTS FROM THE FSS CONTRACT.$0
-
September 26, 2025Mod P00012 · Supplemental Agreement For Work Within Scope42-2A VOLUNTARY PRICE DECREASE FOR 1 PRODUCT$0
-
September 18, 2025Mod P00011 · Supplemental Agreement For Work Within Scope42-2A TEMPORARY PRICE REDUCTION FOR 3 NDCS$0
-
September 12, 2025Mod P00010 · Supplemental Agreement For Work Within ScopePRODUCT ADDITION PROVISIONAL FCP LIFECYCLE CHANGE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79724D0048?
Contract 36F79724D0048 is a federal contract awarded to Moderna Us, Inc. by Department Of Veterans Affairs on September 4, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 10 times since the base award.
Who won contract 36F79724D0048?
Moderna Us, Inc. won contract 36F79724D0048 from Department Of Veterans Affairs.
How much is contract 36F79724D0048 worth?
Contract 36F79724D0048 has obligated $0 to date but carries a potential ceiling of $225,000 if fully funded and all options are exercised.